These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 10639016)
1. COX-2 is not involved in thromboxane biosynthesis by activated human platelets. Patrignani P; Sciulli MG; Manarini S; Santini G; Cerletti C; Evangelista V J Physiol Pharmacol; 1999 Dec; 50(4):661-7. PubMed ID: 10639016 [TBL] [Abstract][Full Text] [Related]
2. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188 [TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526 [TBL] [Abstract][Full Text] [Related]
4. Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings. Panara MR; Padovano R; Sciulli MG; Santini G; Renda G; Rotondo MT; Pace A; Patrono C; Patrignani P Clin Pharmacol Ther; 1998 Jun; 63(6):672-81. PubMed ID: 9663182 [TBL] [Abstract][Full Text] [Related]
5. Human pharmacology of naproxen sodium. Capone ML; Tacconelli S; Sciulli MG; Anzellotti P; Di Francesco L; Merciaro G; Di Gregorio P; Patrignani P J Pharmacol Exp Ther; 2007 Aug; 322(2):453-60. PubMed ID: 17473175 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease. Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573 [TBL] [Abstract][Full Text] [Related]
7. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Schrör K Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351 [TBL] [Abstract][Full Text] [Related]
8. Do human platelets express COX-2? Reiter R; Resch U; Sinzinger H Prostaglandins Leukot Essent Fatty Acids; 2001 Jun; 64(6):299-305. PubMed ID: 11427038 [TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of cyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo. Buerkle MA; Lehrer S; Sohn HY; Conzen P; Pohl U; Krötz F Circulation; 2004 Oct; 110(14):2053-9. PubMed ID: 15451781 [TBL] [Abstract][Full Text] [Related]
10. Selective cyclooxygenase-2 inhibition by nimesulide in man. Cullen L; Kelly L; Connor SO; Fitzgerald DJ J Pharmacol Exp Ther; 1998 Nov; 287(2):578-82. PubMed ID: 9808683 [TBL] [Abstract][Full Text] [Related]
11. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers. Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674 [TBL] [Abstract][Full Text] [Related]
12. Constitutive expression and involvement of cyclooxygenase-2 in human megakaryocytopoiesis. Tanaka N; Sato T; Fujita H; Morita I Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):607-12. PubMed ID: 14726416 [TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis. Belton OA; Duffy A; Toomey S; Fitzgerald DJ Circulation; 2003 Dec; 108(24):3017-23. PubMed ID: 14638539 [TBL] [Abstract][Full Text] [Related]
14. Effects of bisphosphonates on prostaglandin E2 and thromboxane B2 production in human whole blood and monocytes stimulated by lipopolysaccharide and A23187. Tuominen OM; Ylitalo-Heikkala R; Vehmas TI; Mucha I; Ylitalo P; Riutta A Methods Find Exp Clin Pharmacol; 2006; 28(6):361-7. PubMed ID: 16894405 [TBL] [Abstract][Full Text] [Related]
15. Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases. Neupert W; Brugger R; Euchenhofer C; Brune K; Geisslinger G Br J Pharmacol; 1997 Oct; 122(3):487-92. PubMed ID: 9351505 [TBL] [Abstract][Full Text] [Related]
16. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors. Gray PA; Warner TD; Vojnovic I; Del Soldato P; Parikh A; Scadding GK; Mitchell JA Br J Pharmacol; 2002 Dec; 137(7):1031-8. PubMed ID: 12429575 [TBL] [Abstract][Full Text] [Related]
17. Cholera toxin induces prostaglandin synthesis via post-transcriptional activation of cyclooxygenase-2 in the rat jejunum. Beubler E; Schuligoi R; Chopra AK; Ribardo DA; Peskar BA J Pharmacol Exp Ther; 2001 Jun; 297(3):940-5. PubMed ID: 11356914 [TBL] [Abstract][Full Text] [Related]
18. Origins of prostaglandin E2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems. Giuliano F; Warner TD J Pharmacol Exp Ther; 2002 Dec; 303(3):1001-6. PubMed ID: 12438520 [TBL] [Abstract][Full Text] [Related]
19. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation. Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038 [TBL] [Abstract][Full Text] [Related]
20. Assay of cyclooxygenase-1 and 2 in human monocytes. Demasi M; Caughey GE; James MJ; Cleland LG Inflamm Res; 2000 Dec; 49(12):737-43. PubMed ID: 11211927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]